Mechanisms of hormone-mediated carcinogenesis of the ovary in mice

Related Experiment Videos

C C Capen1, W G Beamer, B J Tennent

  • 1Jackson Laboratory, Bar Harbor, ME 04609, USA.

Mutation Research
|December 1, 1995
PubMed

Insights

Ovarian cancer in mice can be triggered by factors that reduce ovarian follicles, leading to hormonal imbalances and tumor development. These hormonal changes, driven by pituitary gonadotropins, increase cancer risk in mice, a mechanism not observed in women.

Area of Science:

  • Reproductive Biology
  • Oncology
  • Genetics

Background:

  • Ovarian carcinogenesis research explores various induction methods in mice.
  • Disruptions in graafian follicle function are linked to ovarian lesions and tumors.
  • Sterility-associated hormonal changes are implicated in mouse ovarian cancer development.

Purpose of the Study:

  • To review mechanisms of experimental ovarian carcinogenesis in mice.
  • To investigate the role of hormonal mediation in sterility-associated ovarian tumors.
  • To compare pathogenetic factors in mouse and human ovarian cancer.

Main Methods:

  • Review of experimental models including X-irradiation, chemical agents, grafting, thymectomy, gene mutations, and aging.
  • Analysis of hormonal feedback loops involving estradiol and pituitary gonadotropins.
  • Examination of ovarian pathology in mutant mice and comparison with human cases.

Main Results:

  • Factors diminishing graafian follicles lead to reduced estradiol secretion.
  • Compensatory overproduction of luteinizing hormone increases ovarian tumor risk in mice.
  • Proliferation of ovarian surface epithelium and stromal cells observed in sterile mice.

Conclusions:

  • Hormonally-mediated carcinogenesis associated with sterility is supported by findings in mutant mice.
  • Reduced ovarian follicle numbers and altered hormone secretion are key pathogenetic factors.
  • Observed mouse ovarian tumors, like tubular adenomas, lack direct counterparts in human ovaries.

Related Concept Videos